Navigation Links
GeneGo Announces Systems Tox Relationship With Entelos
Date:3/17/2009

ST. JOSEPH, Mich., March 17 /PRNewswire/ -- GeneGo, Inc., the leading provider of pathway data mining & analysis solutions, today announced a license agreement with Entelos of Foster City, CA, a company specializing in predictive technologies, including toxicogenomics and PhysioLab(R) virtual human disease models. GeneGo will use Entelos' DrugMatrix(R) gene expression data to further develop GeneGo's Functional Descriptor predictive toxicology models.

"Access to a comprehensive, pharmacologically-diverse and fully annotated compendium of gene expression data is critical to developing high-performance predictive models," said Richard Brennan, Director of Toxicology at GeneGo. "This is one of the key goals of our MetaTox partnership. DrugMatrix is the largest toxicogenomic database available, and will allow us to apply the lessons we have learned from our participation in the Microarray Quality Control Consortium to expand our collection of biological pathway-based classifiers with toxicity models for a wide variety of adverse drug effects in key target tissues."

"We are very pleased to be working with GeneGo and participating in their MetaTox projects," said Alan Roter, VP of Informatics at Entelos. "GeneGo's unique approach of generating functional descriptors is a great complement to the classifiers and predictive models in DrugMatrix, and we see great benefit to the scientific community using predictive toxicogenomics."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of diffe
'/>"/>

SOURCE GeneGo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
2. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
3. Utrecht University Licenses MetaDrug From GeneGo for Drug Innovation
4. GeneGo Integrates With Cytoscape
5. UC Berkeley Expands Molecular Toxicology Curriculum to Include GeneGos Platform
6. GSK Extends GeneGo License and Adds New Products
7. GeneGo Collaborates With The Netherlands Toxicogenomics Center on $100 Million Grant
8. VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics
9. Unilever Extends Their GeneGo MetaCore License
10. Yale Keck Microarray Center Becomes a GeneGo Center of Excellence
11. University of Miami Miller School of Medicine Becomes a GeneGo Center of Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... FAYETTEVILLE, Ark. (PRWEB) March 03, 2015 ... Resource Systems Inc. to their international sales network. ... efficient gas dissolution technology to Canada’s Atlantic Provinces, ... Systems has served as one of Canada’s premiere ... clients in both the municipal water and wastewater ...
(Date:3/3/2015)... March 03, 2015 The winners of ... were honored by the Global Supply Chain Resiliency ... took place on Wednesday, February 25th, 2015, at the ... was formed to bring together supply chain risk management ... advance the professional discipline through opportunities to collaborate, develop ...
(Date:3/3/2015)...  Rosa & Co. LLC, a drug development advisory ... today announced it has two posters scheduled to be ... and Therapeutics meeting in New Orleans, LA ... - http://photos.prnewswire.com/prnh/20150302/179058LOGO   Bristol- Myers ... a quantitative systems pharmacology approach for immuno-oncology drug development ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Genedata, ... drug discovery and life science research, today announced ... (TM) enterprise platform for use at Pfizer biopharma ... Europe. Genedata is supporting Pfizer’s global deployment and ... (GBT), Centers for Therapeutic Innovation (CTI), and Pharmaceutical ...
Breaking Biology Technology:BlueInGreen® Continues Canadian Expansion, Partners with Resource Systems Inc. 2Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3
... ... ... , ... ...
... ... Agribusiness Association of Iowa, , ... Philadelphia (PRWEB) February 23, 2010 -- Bob Trogele, Ph.D., North America Area ... at the Ag Industry & Crop Management Conference, part of the Agribusiness Showcase & ...
... ... ... ... ...
Cached Biology Technology:Predicted Second Wave of Biotech Growth and Development Begins 2Predicted Second Wave of Biotech Growth and Development Begins 3Predicted Second Wave of Biotech Growth and Development Begins 4Predicted Second Wave of Biotech Growth and Development Begins 5Predicted Second Wave of Biotech Growth and Development Begins 6Predicted Second Wave of Biotech Growth and Development Begins 7Predicted Second Wave of Biotech Growth and Development Begins 8Predicted Second Wave of Biotech Growth and Development Begins 9Predicted Second Wave of Biotech Growth and Development Begins 10Predicted Second Wave of Biotech Growth and Development Begins 11FMC Agricultural Products Executive Bob Trogele Speaks to the Iowa Agribusiness Showcase & Conference 2FMC Agricultural Products Executive Bob Trogele Speaks to the Iowa Agribusiness Showcase & Conference 3Longhorn Vaccines & Diagnostics LLC Receives FDA Emergency Use Authorization (EUA) for the First 2009 H1N1 Influenza Assay to Include a Molecular Transport Medium (MTM) 2Longhorn Vaccines & Diagnostics LLC Receives FDA Emergency Use Authorization (EUA) for the First 2009 H1N1 Influenza Assay to Include a Molecular Transport Medium (MTM) 3Longhorn Vaccines & Diagnostics LLC Receives FDA Emergency Use Authorization (EUA) for the First 2009 H1N1 Influenza Assay to Include a Molecular Transport Medium (MTM) 4Longhorn Vaccines & Diagnostics LLC Receives FDA Emergency Use Authorization (EUA) for the First 2009 H1N1 Influenza Assay to Include a Molecular Transport Medium (MTM) 5Longhorn Vaccines & Diagnostics LLC Receives FDA Emergency Use Authorization (EUA) for the First 2009 H1N1 Influenza Assay to Include a Molecular Transport Medium (MTM) 6
(Date:1/22/2015)... 2015  Today, FreeWavz ( www.FreeWavz.com ), the developer ... on Fundable, https://www.fundable.com/freewavz . FreeWavz will be ... to meet customer demand. Logo - ... Invented by Dr. ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of insulin ... other mental capabilities in adults with mild cognitive impairment ... led by researchers at Wake Forest Baptist Medical Center. ... with amnesic mild cognitive impairment (MCI) or mild to ...
(Date:1/22/2015)... 2015  Analyst Report Issued by Small Cap IR. In 2011, ... planet-wide, transactions at merchants on the leading payment cards rose ... credit, debit, and prepaid cards reached 6.54 billion.  Eight million ... card usage in 2012, and credit and debit card fraud ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... The Juvenile Diabetes Research Foundation announced today that ... New Zealand-based biotechnology company focused on developing cell based ... the safety and effectiveness of transplanting encapsulated insulin-producing cells ... with significant hypoglycemia unawareness. Through its Industry ...
... , April 27 Southwest Bancorp, Inc. (Nasdaq: OKSB ), ... shares of common stock at a price to the public of $12.50 ... offering was increased from the previously announced offering size of approximately $40 ... . , , , ...
... April 27 FTI Consulting, Inc. (NYSE: FCN ), the ... announced today that it will release financial results for the first quarter ended ... 5, 2010 . , , , ... held to discuss financial results on Wednesday, May 5, 2010 at ...
Cached Biology News:JDRF partners with LCT to test encapsulated cell replacement therapy for the treatment of diabetes 2JDRF partners with LCT to test encapsulated cell replacement therapy for the treatment of diabetes 3Southwest Bancorp, Inc. Announces Pricing of $50 Million Underwritten Public Offering of Common Shares 2Southwest Bancorp, Inc. Announces Pricing of $50 Million Underwritten Public Offering of Common Shares 3FTI Consulting, Inc. to Release First Quarter 2010 Results and Host Conference Call 2
... Kit, Linear Template is designed for use with ... No. 3 186 148, 3 186 156). The ... constructs by PCR containing and optimized control region ... RNA polymerase and prokaryotic cell lysate. Flexible positioning ...
... Receptor (GR) Competitor Assay Kits are ideal ... compounds. The PolarScreen GR Competitor Assay Kits ... buffer, and one of the following proprietary ... kit), GS Red (red assay kit), or ...
... Roches RTS AviTag E. coli Biotinylation Kit, Plasmid ... and 500 E. coli expression kits. (Cat. No. ... 461). This kit provides vectors for the easy ... sequence. The expressed protein can be enzymatically mono-biotinylated ...
... sensitive, fast and specific detection of chromosomal ... Short hybridisation time ( ... Multiplex capability Available with different ... Probes available with different labels. Related ...
Biology Products: